Ductal Carcinoma in Situ State of the Art Review Online Course, web

Event Organized by:
Radiological Society of North America


Learn More about Radiological Society of North America

Ductal Carcinoma in Situ: State-of-the-Art Review

Radiological Society of North America  logo

The goal of the Radiology articles designated for self-assessment CME and their accompanying tests is to increase understanding of the radiologic characteristics of a variety of pathologic conditions and basic physics principles.


Content Areas (Codes):
The following Content Areas will be printed on the certificate for this course:

  • Breast (Imaging and Interventional)


Learning Objectives:

  • Explain the uncertainty in the natural history of ductal carcinoma in situ (DCIS).
  • Describe the common and uncommon imaging presentations of DCIS.
  • Identify the nonstandard treatment options for DCIS via active surveillance.


This journal-based CME activity is estimated to take 1 hour to complete.


Start Date: 12/21/2021
End Date for CME Eligibility/Online Expiration Date: 12/20/2024



  • Lars J. Grimm, MD, MHS
  • Habib Rahbar, MD
  • Monica Abdelmalak, MD
  • Allison H. Hall, MD, PhD
  • Marc D. Ryser, PhD


Disclosure Statements:
The ACCME requires that the RSNA, as an accredited provider of CME, disclose the relevant financial relationships of the planners, faculty, and any other individuals in a position to control content of this activity. If there is a relevant financial relationship that has been disclosed, please find it below:



  • David A. Bluemke, MD, PhD: Consultant, Bayer, Guidepoint Global; Data safety monitoring board, ACRIN.
  • John A. Carrino, MD, MPH: Research consultant, Pfizer, Covera, Globus, Carestream, Image Analysis Group (IAG), Image Biopsy Lab.
  • Birgit B. Ertl-Wagner, MD, MHBA: Author, Springer, Thieme; Spouse, Employee, Siemens Healthineers.
  • Kathryn J. Fowler, MD: Grant support, Bayer, Pfizer, GE; Institutional consulting, GE.
  • Vicky J. Goh, MBBCh: Institutional research grant, Siemens Healthcare; Author, Oxford University Press; Travel grant, Siemens Healthcare.
  • David F. Kallmes, MD: Research support, MicroVention, Medtronic, Insera Theraputics, Balt, Monarch Biosciences, Ceranovus; Advisory Board, Triticum; Data safety monitoring board, NoNO, Vesalio, Minnetronix; Stockholder, Marblehead Medical, Superior Medical Experts, Kypheze Medical, Conway Medical, Nested Knowledge.
  • Michael H. Lev, MD: Institutional grant, GE Healthcare, Siemens Healthineers; Consultant, GE Healthcare, Takeda/Roche-Genentech.
  • Linda Moy, MD: Research grant, Siemens; Advisory board, Lunit, iCAD; Stock options, Lunit.
  • Mizuki Nishino, MD, MPH: Institutional research grants, Daiichi Sankyo, AstraZeneca, Canon Medical Systems, Merck investigator studies program; Consultant, Daiichi Sanko, AstraZeneca.
  • Mark L. Schiebler, MD: Grant, National Heart, Lung, and Blood Institute; Shareholder, X-Vax, Healthmyne, Stemina Biomarker Discovery.
  • Clifford R. Weiss, MD: Grants, BCSI, Medtronic Guerbet, BTG, Siemens Healthcare; Consultant, Medtronic, Siemens Healthcare, BSCI.
  • L.J.G.: Grants from ECOG/ACRIN (TMIST), Alliance for Clinical Trials in Oncology Foundation, AUR Breast Cancer Research Foundation, and MD Anderson Cancer Center; consulting fees from Hologic, Medscape, and Reference; payment for expert testimony from Hare Wynn, Thompson Miller, Simpson ZCK Law; leadership or fiduciary role in Society of Breast Imaging.
  • H.R.: Grant funding from GE Healthcare (not related to work).
  • A.H.H.: Grants from Cancer Research UK (Prime), Department of Defense, and Susan G. Komen for the Cure.


All other individuals in control of content have indicated that there are no relevant financial relationships with any commercial interests to be disclosed.


Accreditation and Designation Statements:
The Radiological Society of North America (RSNA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


This journal-based CME activity can be applied towards the ABR MOC self-assessment requirement (SA-CME).


To earn CME credit, participants must correctly answer a minimum of 80% of the post-test questions and complete the course evaluation.


The RSNA designates this journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Non-member Rate: $35.00
Member Rate: $0.00

Refund / Exchange Policy:
RSNA will not issue any refunds or exchanges for online only versions of educational products or activities purchased online. Please review the entire product or activity description prior to purchase.

RSNA Disclaimer:
The opinions or views expressed in this activity are those of the presenters and do not necessarily reflect the opinions, recommendations or endorsement of the RSNA. Participants should critically appraise the information presented and are encouraged to consult appropriate resources for information surrounding any product or device mentioned. Information presented, as well as publications, technologies, products and/or services discussed, are intended to inform the learner about the knowledge, techniques, and experiences of RSNA faculty who are willing to share such information with colleagues. The RSNA disclaims any and all liability for damages to any individual user for all claims which may result from the use of said information, publications, technologies, products and/or services, and events.

Event Organized by:
Radiological Society of North America

Date: Dec 20 2024

Venue: Online Course

Address: - Online Course, web

Need additional information about this event?

The well being and aesthetics industry is growing rapidly which means selecting right training is more important than ever. Botox training courses must keep pace with the standards and regulations in the industry to ensure patient safety. In the anti-aging market the injectable serum, Botulinum Toxin more commonly known as Botox, has become one of the top procedures for the effective treatment of fine lines and wrinkles. Once the preserve of the rich and famous, this wonder-treatment now has a long track record of success and safety making it a highly desirable procedure for a more youthful and healthy appearance.

If you are considering becoming a Botox clinician you will want the best Botox training available today, training that gives you a full understanding of the product and how to administer it safely with outstanding results for your clients every time. Aesthetic Education, promotes Botox Courses that are at the leading edge of training in aesthetics procedures with the best qualification for doctors, nurses and dentists, courses that are superior in meeting the guidelines which all practitioners must adhere to. The depth of learning and hands-on practice will equip you and your teams with the knowledge and experience you need to be fully regulated and confident to deliver safe and outstanding services at your practice.

We provide courses in the following countries and cities:

Botox Training and Dermal Fillers for Argentina, Bolivia, Brasil, Chile, Colombia, Costa Rica, Cuba, Dominica, Republica Dominicana, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela.

MD.Education | The Next Step in Medical Learning


MD Courses

Pain Management Courses

Medical Courses

Who We Are

    We are a group of medical professionals ready to share with you the best products and techniques.


Copyright 2023 MD.Education - All rights reserved. - Botox® is a registered trademark of Allergan, Inc.